Print

F4/AS01

A Dose-ranging Study to Compare the Safety and Immunogenicity of a Candidate HIV Vaccine 732461, Adjuvanted or Not, Administered According to a 0, 1 Month Schedule to Healthy Adult HIV Seronegative Volunteers..

Trial Details:

I/II Completed
GlaxoSmithKline February 01, 2007
F4/AS01 Nef, reverse transcriptase, Pol, and Gag p24 and p17
F4/AS01 Protein
Belgium 180
NCT00434512
http://clinicaltrials.gov/show/NCT00434512